Western researchers (Dr. Monroe E. Wall of the USDA and Jonathon
Hartwell of the
National Cancer Institute) first discovered Camptotheca's
anticancer properties in 1958. In 1966, after Wall joined the Research Triangle Institute, he and other
researchers isolated camptothecin. A camptothecin analog (camptothecin
sodium) was tested on gastrointestinal cancer patients in the early 70's,
but the clinical trials were discontinued because the patients suffered
severe side effects. Researchers continued to investigate camptothecin to
develop drugs with fewer side effects, and their work began to bear fruit
in the late 80's.
In China, camptothecin has been used to treat
leukemia and cancers
(carcinomas) of
the stomach and liver.
For more information, visit:
Reference:
Duke, James A., and Edward S. Ayensu. 1985. Medicinal Plants of
China. Algonac, MI, Reference Publications, Inc.
[BioTech Home | Cyberbotanica Home | Bibliography | Self-Test | ]
URL: http://biotech.icmb.utexas.edu/botany/camphist.html
Cyberbotanica is maintained by Lucy A. Snyder.
Please send her
e-mail if you spot any errors in these pages, or if you have
any suggestions or comments. All
material Copyright 1998, BioTech
Resources.
This page was last updated on 7/21/98.